FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)
$12.7 -0.3 (-2.3077%)
Analysed FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) News Sources
Quest Diagnostics Q1 Earnings Call Highlights
21-04-2026
marketbeat.com
CMS Grants Fresenius Kabi COVID-19 Indication-Specific HCPCS Codes for Tyenne® (tocilizumab-aazg)
09-04-2026
yahoo.com
Fresenius Medical Care AG (FMS) Looks to Improve Profitability After Smashing Q4 Expectations
13-03-2026
yahoo.com
Here's Why Fresenius (FMS) is a Strong Value Stock
05-03-2026
yahoo.com
Assessing Fresenius SE KGaA (XTRA:FRE) Valuation After Recent Earnings And Shareholder Returns
01-03-2026
yahoo.com
Pacira BioSciences, Inc. Q4 2025 Earnings Call Summary
27-02-2026
moby.co
Pacira BioSciences Q4 Earnings Call Highlights
27-02-2026
marketbeat.com
Fresenius SE & Co KGaA (FSNUY) Full Year 2025 Earnings Call Highlights: Strong Organic ...
25-02-2026
yahoo.com
Fresenius Medical Care AG & Co. KGaA Q4 Earnings Call Highlights
24-02-2026
marketbeat.com
Fresenius: Q4 Earnings Snapshot
24-02-2026
yahoo.com
What is the current price of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)?
The current price of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) is $12.7.
FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) since the previous trading day is $-0.3.
FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) since the previous trading day is -2.3077%.
What is the most recent average sentiment score for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)?
The most recent average sentiment score for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) is 72 out of 100.
What is the most recent average sentiment for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)?
The most recent sentiment for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) is .
SEC-8K** Filing Available For FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.